Global Tamiflu (Oseltamivir Phosphate) Market: Introduction
The global tamiflu (oseltamivir phosphate) market is witnessing a continuously changing market dynamics. Oseltamivir is an antiviral medication utilized to prevent and treat influenza A and B. Commercially, it is sold under the brand name Tamiflu. Although the U.S. FDA approved oseltamivir phosphate for the treatment of influenza in human in 1999; however, the first generic version of Tamiflu gained approval in 2016 only.
In this research report, the global tamiflu (oseltamivir phosphate) market has been assessed thoroughly, using the quantitative and qualitative assessment techniques. Further, it has estimated the performance of this market over the period from 2019 to 2027 on the basis of various prominent trends and the market dynamics. The report also offers a detailed assessment of the key segments of this market and each of the regional markets for tamiflu (oseltamivir phosphate) across the world.
Need an Overview of the Report on Tamiflu Market? Ask for the Brochure here
Global Tamiflu (Oseltamivir Phosphate) Market: Notable Developments
The global tamiflu (oseltamivir phosphate) market is not much competitive as there is only player in this market. F. Hoffmann La Roche is the originator of this drug. Gilead Sciences discovered oseltamivir using shikimic acid as the starting point for the synthesis and exclusively licensed their relevant patents to F. Hoffmann La Roche in 1996. Recently Genentech, a sister concern of Roche, announced that the third phase of MINISTONE-2 clinical trial has touched its primary endpoint, showcasing that its new drug, Xofluza (baloxavir marboxil), could be equated to its own blockbuster drug, Tamiflu (oseltamivir). The tests demonstrated that Xofluza was also well-tolerated in kids, suffering with the flu.
In another event, Sanofi entered into an agreement with F. Hoffmann La Roche for exclusive over-the-counter rights to Tamiflu® for the treatment of influenza in the U.S. According to the terms of the agreement, Sanofi will be leading the FDA negotiations for the over-the-counter shift and the subsequent exclusive rights for marketing, scientific engagement, and the distribution of Tamiflu OTC in the country. As of now, Genentech sells Tamiflu in the U.S.
Stuck in a Neck-to-Neck Competition with other Brands? Request a Custom Report on “Tamiflu Market” here
Global Tamiflu (Oseltamivir Phosphate) Market Dynamics
Although, Tamiflu® is a parented property of F. Hoffmann La Roche; other pharmaceutical companies can produce and sell this drug in Thailand, Indonesia, Philippines, and several other Asian countries as the drug is not been patent protected in these nations. The presence of local players has created a competitive environment for Tamiflu in these domestic markets. The dearth of awareness among people in developing regions is also impacting the global tamiflu (oseltamivir phosphate) market negatively.
North America Leads Global Tamiflu (Oseltamivir Phosphate) Market
The global tamiflu (oseltamivir phosphate) market mainly reports its presence across North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Among these, North America has acquired the leading position, reason being the only company that officially produces the drug headquartered in the U.S. Roche has continuously been working on research and development of Tamiflu to improve its efficacy, which is supporting the North America tamiflu (oseltamivir phosphate) market remarkably. With no major competitor in sight, this regional market is likely to remain on the top over the next couple of years.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.